ArticleCytotherapy2026
The effects of hypothermic storage on passaged chondrocyte viability and redifferentiation potential.
Article in Cytotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Scaffold-free generation of non-contractile bioengineered cartilage to investigate the effects of inflammatory mediators on human chondrocytes.Science and engineering journal · 2025Article
Corrections and comments
- Update of
Authors and funding
7 authors.
Funding
Abstract
Autologous chondrocyte implantation (ACI) is a cell-based therapy used to treat focal articular cartilage defects. In ACI, chondrocytes from nonload-bearing healthy cartilage regions are isolated and sent to a cell manufacturing laboratory, where they are expanded for cell number in monolayer culture. The expanded cells are then transported back to the clinic for reimplantation into the defect site. The storage and transport conditions from the cell manufacturing facility to the clinic implantation may influence reparative potential. However, the impact of acute hypothermic storage of passaged chondrocyte, which is thought to preserve cell viability, is not fully known. Here, we tested the hypothesis that acute hypothermic storage negatively impacts passaged chondrocyte viability and reduces the capacity for redifferentiation. Passaged chondrocytes were stored either in monolayer culture or in suspension at 36°C, 19°C or 8°C. In monolayer culture, hypothermic temperatures preserved cell viability, promoted cell rounding, reduced proliferation, depolymerized filamentous actin and reduced the mRNA levels of specific matrix molecules compared to 36°C. The effects of hypothermia were context-dependent. Exposure of passaged cells in suspension to hypothermia promoted cell viability and reduced cell aggregation. At 8°C, cells in suspension enhanced expression of specific matrix molecule mRNA levels. Subsequently, when cells in suspension at 8°C were seeded in three-dimensional within agarose molds, aggrecan expression was enhanced and formed thicker tissues. Therefore, in contrast to our hypothesis, we found that hypothermic storage did not have a negative impact; when stored for 1 day in suspension, it had lasting effects on matrix deposition. The storage of passaged chondrocytes under hypothermic conditions may be beneficial for ACI, warranting further investigations of cell hypothermic storage for in vivo repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.